The Efficacy and Safety of Xinjia Xuanbai Chengqi Granules in Acute Exacerbation of COPD: A Multicentre, Randomised, Double-Blind, Controlled Trial.
Ruihan QiHong-Chun ZhangDemin LiFeng GaoQing MiaoSheng ChenYan HuangLei WuZhen-Hui LuHaibo HuErran LiZhibin ChenPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
XJXBCQ is beneficial and safe for AECOPD treatment and could be considered an adjunctive therapy for promoting the relief of clinical symptoms. This trial is registered with ChiCTR1800016915.
Keyphrases
- double blind
- study protocol
- clinical trial
- placebo controlled
- phase iii
- chronic obstructive pulmonary disease
- phase ii
- open label
- randomized controlled trial
- respiratory failure
- liver failure
- lung function
- sleep quality
- intensive care unit
- extracorporeal membrane oxygenation
- cystic fibrosis
- combination therapy
- mechanical ventilation
- cross sectional